United States Ipilimumab Market Report 2016

December 2016 | 102 pages | ID: U09AE97FD90EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Ipilimumab

Revenue, means the sales value of Ipilimumab

This report studies sales (consumption) of Ipilimumab in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer
• Novartis
• Bayer
• Roche
• Bristol-Myers Squibb
• Merck & Co.
• Exelixis

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Ipilimumab in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Ipilimumab Market Report 2016

1 IPILIMUMAB OVERVIEW

1.1 Product Overview and Scope of Ipilimumab
1.2 Classification of Ipilimumab
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Ipilimumab
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Ipilimumab (2011-2021)
  1.4.1 United States Ipilimumab Sales and Growth Rate (2011-2021)
  1.4.2 United States Ipilimumab Revenue and Growth Rate (2011-2021)

2 UNITED STATES IPILIMUMAB COMPETITION BY MANUFACTURERS

2.1 United States Ipilimumab Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Ipilimumab Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Ipilimumab Average Price by Manufactures (2015 and 2016)
2.4 Ipilimumab Market Competitive Situation and Trends
  2.4.1 Ipilimumab Market Concentration Rate
  2.4.2 Ipilimumab Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES IPILIMUMAB SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Ipilimumab Sales and Market Share by Type (2011-2016)
3.2 United States Ipilimumab Revenue and Market Share by Type (2011-2016)
3.3 United States Ipilimumab Price by Type (2011-2016)
3.4 United States Ipilimumab Sales Growth Rate by Type (2011-2016)

4 UNITED STATES IPILIMUMAB SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Ipilimumab Sales and Market Share by Application (2011-2016)
4.2 United States Ipilimumab Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES IPILIMUMAB MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Ipilimumab Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Novartis
  5.2.2 Ipilimumab Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Novartis Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Bayer
  5.3.2 Ipilimumab Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Bayer Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Roche
  5.4.2 Ipilimumab Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Roche Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Bristol-Myers Squibb
  5.5.2 Ipilimumab Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Bristol-Myers Squibb Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Merck & Co.
  5.6.2 Ipilimumab Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Merck & Co. Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Exelixis
  5.7.2 Ipilimumab Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Exelixis Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview

6 IPILIMUMAB MANUFACTURING COST ANALYSIS

6.1 Ipilimumab Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Ipilimumab

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Ipilimumab Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Ipilimumab Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES IPILIMUMAB MARKET FORECAST (2016-2021)

10.1 United States Ipilimumab Sales, Revenue Forecast (2016-2021)
10.2 United States Ipilimumab Sales Forecast by Type (2016-2021)
10.3 United States Ipilimumab Sales Forecast by Application (2016-2021)
10.4 Ipilimumab Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Ipilimumab
Table Classification of Ipilimumab
Figure United States Sales Market Share of Ipilimumab by Type in 2015
Table Application of Ipilimumab
Figure United States Sales Market Share of Ipilimumab by Application in 2015
Figure United States Ipilimumab Sales and Growth Rate (2011-2021)
Figure United States Ipilimumab Revenue and Growth Rate (2011-2021)
Table United States Ipilimumab Sales of Key Manufacturers (2015 and 2016)
Table United States Ipilimumab Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Ipilimumab Sales Share by Manufacturers
Figure 2016 Ipilimumab Sales Share by Manufacturers
Table United States Ipilimumab Revenue by Manufacturers (2015 and 2016)
Table United States Ipilimumab Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Ipilimumab Revenue Share by Manufacturers
Table 2016 United States Ipilimumab Revenue Share by Manufacturers
Table United States Market Ipilimumab Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Ipilimumab Average Price of Key Manufacturers in 2015
Figure Ipilimumab Market Share of Top 3 Manufacturers
Figure Ipilimumab Market Share of Top 5 Manufacturers
Table United States Ipilimumab Sales by Type (2011-2016)
Table United States Ipilimumab Sales Share by Type (2011-2016)
Figure United States Ipilimumab Sales Market Share by Type in 2015
Table United States Ipilimumab Revenue and Market Share by Type (2011-2016)
Table United States Ipilimumab Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Ipilimumab by Type (2011-2016)
Table United States Ipilimumab Price by Type (2011-2016)
Figure United States Ipilimumab Sales Growth Rate by Type (2011-2016)
Table United States Ipilimumab Sales by Application (2011-2016)
Table United States Ipilimumab Sales Market Share by Application (2011-2016)
Figure United States Ipilimumab Sales Market Share by Application in 2015
Table United States Ipilimumab Sales Growth Rate by Application (2011-2016)
Figure United States Ipilimumab Sales Growth Rate by Application (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Ipilimumab Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Ipilimumab Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Ipilimumab Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Ipilimumab Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Ipilimumab Sales Market Share (2011-2016)
Table Merck & Co. Basic Information List
Table Merck & Co. Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co. Ipilimumab Sales Market Share (2011-2016)
Table Exelixis Basic Information List
Table Exelixis Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Exelixis Ipilimumab Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ipilimumab
Figure Manufacturing Process Analysis of Ipilimumab
Figure Ipilimumab Industrial Chain Analysis
Table Raw Materials Sources of Ipilimumab Major Manufacturers in 2015
Table Major Buyers of Ipilimumab
Table Distributors/Traders List
Figure United States Ipilimumab Production and Growth Rate Forecast (2016-2021)
Figure United States Ipilimumab Revenue and Growth Rate Forecast (2016-2021)
Table United States Ipilimumab Production Forecast by Type (2016-2021)
Table United States Ipilimumab Consumption Forecast by Application (2016-2021)